glp 1 agonist stands for GLP-1 Agonists - What is it? GLP-1 for Diabetes vs GLP-1
Description
Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness
Ozempic, Wegovy, Mounjaro , and Zepbound all play significant roles in the sphere of weight management, though they differ in their mechanisms and areas of impact
Fusco J et al (2017): GLP-1/Exendin-4 induces -cell proliferation via the epidermal growth factor receptor
Victoza (liraglutide): Approved for type 2 diabetes management via daily injection
doi: 10.1111/dom.12596
